Jim Simons Fibrogen Inc Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Fibrogen Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,358,712 shares of FGEN stock, worth $760,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,358,712

Previous 753,140 80.41%

Holding current value

$760,878

Previous $301,000 139.2%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.3 - $0.58 $181,671 - $351,231	605,572 Added 80.41%	1,358,712 $720,000
Q3 2024 Nov 13, 2024	BUY	$0.33 - $1.26 $248,536 - $948,956	753,140 New	753,140 $301,000
Q1 2024 May 13, 2024	SELL	$0.73 - $2.73 $377,345 - $1.41 Million	-516,912 Reduced 75.64%	166,500 $391,000
Q4 2023 Feb 13, 2024	BUY	$0.38 - $0.91 $238,416 - $570,944	627,412 Added 1120.38%	683,412 $606,000
Q3 2023 Nov 14, 2023	BUY	$0.79 - $2.83 $44,240 - $158,480	56,000 New	56,000 $48,000
Q1 2023 May 12, 2023	SELL	$15.95 - $25.18 $3.54 Million - $5.59 Million	-222,200 Reduced 72.71%	83,400 $1.56 Million
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $6.49 Million - $8.68 Million	-489,400 Reduced 61.56%	305,600 $4.9 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $448,020 - $573,780	39,300 Added 5.2%	795,000 $10.3 Million
Q2 2022 Aug 12, 2022	BUY	$7.94 - $12.96 $538,332 - $878,688	67,800 Added 9.86%	755,700 $7.98 Million
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $7.08 Million - $9.89 Million	588,800 Added 594.15%	687,900 $8.27 Million
Q4 2021 Feb 11, 2022	SELL	$9.93 - $15.39 $1.09 Million - $1.69 Million	-109,539 Reduced 52.5%	99,100 $1.4 Million
Q3 2021 Nov 12, 2021	BUY	$10.18 - $26.64 $2.12 Million - $5.56 Million	208,639 New	208,639 $2.13 Million
Q2 2021 Aug 13, 2021	SELL	$18.57 - $35.68 $584,955 - $1.12 Million	-31,500 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$31.0 - $55.72 $471,200 - $846,944	15,200 Added 93.25%	31,500 $1.09 Million
Q4 2020 Feb 10, 2021	BUY	$37.09 - $48.97 $604,567 - $798,211	16,300 New	16,300 $605,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $14.1 Million - $15.8 Million	-347,200 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $11.3 Million - $14.9 Million	347,200 New	347,200 $14.1 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

37.4M

Call Options Held

351K

Put Options Held

105K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $52.5M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account